Skip to main content
. 2005 May 24;33(9):2942–2951. doi: 10.1093/nar/gki578

Scheme 1.

Scheme 1

(a) MMTrCl, pyridine then Ac2O, DMAP; (b) 80% aq. AcOH; (c) 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-one, pyridine–DMF; (d) bis(tri-n-butylammonium)pyrophosphate in DMF, Bu3N; (e) 1% iodine in pyridine–H2O then NH4OH.